Bild 1 von 1
Standardbild
Bild 1 von 1
Standardbild
Medicine Ser.: Formaldehyde 2-Butoxyethanol And 1-Tert-Butoxy-2-propanol by The International Agency for Research on Cancer (2006, Trade Paperback)
Wonder Book and Video (627652)
99,6% positive Bewertungen
Preis:
US $20,51
(inkl. MwSt.)
Ca.CHF 16,55
+ $19,69 Versand
Rücknahme:
30 Tage Rückgabe. Käufer zahlt Rückversand. Wenn Sie ein eBay-Versandetikett verwenden, werden die Kosten dafür von Ihrer Rückerstattung abgezogen.
Artikelzustand:
- Sofort-KaufenFormaldehyd 2-Butoxyethanol und 1-Tert-Butoxy-2-Propanol (IARC Monographien auf t
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
Über dieses Produkt
Product Identifiers
PublisherWorld Industries Health Organization
ISBN-109283212886
ISBN-139789283212881
eBay Product ID (ePID)59058501
Product Key Features
Number of Pages483 Pages
Publication NameFormaldehyde 2-1-Tert-Butoxy-2-Propanol
LanguageEnglish
SubjectPublic Health, Preventive Medicine, Oncology
Publication Year2006
TypeTextbook
Subject AreaMedical
AuthorThe International Agency for Research on Cancer
SeriesMedicine Ser.
FormatTrade Paperback
Dimensions
Item Height1 in
Item Weight28.9 Oz
Item Length9.5 in
Item Width6.8 in
Additional Product Features
Series Volume Number88
SynopsisThis eighty-eighth volume of IARC Monographs evaluates the available evidence on the carcinogenic potential in humans of formaldehyde, 2-butoxyethanol and 1-tert-butoxypropan-2-ol. Formaldehyde, a potential carcinogen that is found in the workplace and in the environment, has been studied the most widely and has been evaluated three times previously. It is being re-evaluated this time following a recommendation from an Advisory group that identified formaldehyde as a high priority for future re-evaluation, based on the availability of complex mechanistic data and the anticipated publication of new epidemiological studies that became available soon afterwards. The same Advisory Group also identified 2-butoxyethanol and other glycol ethers as high priorities, based on the availability of new carcinogenesis bioassays conducted by the US National Toxicology Program. This is the first evaluation that IARC has made to the two-glycol ethers.
